Print（PDF/59KB） Feb. 03, 2011 Finances

Revision of Financial Forecasts for the Fiscal Year Ending March 31, 2011

Dainippon Sumitomo Pharma Co., Ltd. announces revisions of its financial forecasts for the year ending March 31, 2011, which reflects changes in the Company's business performances since the previous forecasts announced on October 29, 2010.

(Millions of yen)

1. Revision of Consolidated Financial Forecasts for the Year Ending March 31, 2011

	Net sales	Operating income	Ordinary income	Net income	Earnings per share
Previous Forecasts (A)	365,000	18,000	15,500	9,000	¥22.65
New forecasts (B)	365,000	22,000	19,500	11,000	¥27.69
(B)－(A)	－	4,000	4,000	2,000
Change (%)	－	22.2	25.8	22.2
(Reference) Results for the year ended March 31, 2010	296,261	35,624	33,837	20,958	¥52.75

2. Reason for revision

Net sales are expected to proceed according to the previous financial forecasts.
However, on the cost side, selling, general and administrative expenses are expected to decrease from the previous forecasts, mainly due to a decrease in research and development costs.
Consequently, in the revised consolidated financial forecasts for the year ending March 31, 2011, the Company anticipates that net sales are in accordance with the previous forecasts, 365.0 billion yen, operating income increases 4.0 billion yen to 22.0 billion yen, ordinary income increases 4.0 billion yen to 19.5 billion yen and net income increases 2.0 billion yen to 11.0 billion yen compared to the previous forecasts dated October 29, 2010.

Note: Forecasts shown above are based on management's assumptions and beliefs in light of the information currently available, and involves risks and uncertainties. Actual financial results may differ materially depending on a number of factors, including economic conditions.